Merit Medical Systems, Inc. (MMSI)
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.81 per share a year ago.
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
Merit Medical's (MMSI) latest asset acquisition is likely to expand its endoscopy portfolio with a minimally-invasive solution for GERD patients, thereby improving patient outcomes.
Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical (MMSI) Recalls Syringes Made by Jiangsu Shenli
Merit Medical (MMSI) recalls certain products containing syringes made by a Chinese manufacturer, Jiangsu Shenli.
Merit Medical: Undervalued With Multiple Growth Drivers In Play
Merit Medical has shown solid performance with revenue and EBITDA growth, but has only tracked the broader med-tech market higher as investors wait for more exciting drivers. The company's WRAPSODY endovascular stent graft has potential to exceed management's projections, and could be a practice-changing $100M+ product with good clinical data. Merit's December 2023 convertible debt offering was well in excess of corporate needs, which leads me to believe that M&A is back on the table.
Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says
The U.S. Food and Drug Administration said on Friday that Merit Medical Systems has initiated a recall for plastic syringes supplied by Jiangsu Shenli Medical Production.
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical (MMSI) Up 5% Since Last Earnings Report: Can It Continue?
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock?
